期刊
MICROBIAL CELL FACTORIES
卷 14, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s12934-015-0229-1
关键词
Beneficial microbes; Probiotic; Regulation; Safety; Gastro Intestinal (GI) tract
资金
- FPARIS collaborative project
- Vitagora Competitive Cluster
- French FUI (Fond Unique Interministeriel
- FUI) [F1010012D]
- FEDER (Fonds Europeen de Developpement Regional
- Bourgogne) [34606]
- Burgundy Region
- Conseil General 21
- Grand Dijon
This paper concerns the procedure and the scientific approach to obtain market authorization for a microorganism to be recognized as a novel food with a health claim. Microorganisms that have not been traditionally used during food production in Europe prior to 1997 are considered as novel foods, which should undergo an in-depth characterization and safety assessment before being authorized on the European market. If a novel food bacterium is claimed to provide a beneficial effect on health, these claims must also be investigated before they can be authorized. Some requirements to obtain novel food certification are shared with those required to obtain a health claim. Although regulation exists that deals with these issues for foods in general, bacteria in food raise a specific set of questions that are only minimally addressed in official documentation. We propose a framework and suggest a list of criteria that should be assessed to obtain marketing authorization and health claim for a bacterium in accordance with European health policy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据